What is the characteristic bone marrow flow cytometry immunophenotype in classic hairy-cell leukemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Bone Marrow Flow Cytometry in Classic Hairy Cell Leukemia

Classic HCL demonstrates a highly characteristic immunophenotype on bone marrow flow cytometry showing bright expression of B-cell markers (CD19, CD20, CD22) combined with positivity for CD11c, CD25, CD103, and CD123—this specific combination distinguishes it from other B-cell lymphoproliferative disorders. 1

Core Immunophenotypic Profile

The flow cytometry panel reveals:

B-Cell Lineage Markers (Universally Positive)

  • CD19, CD20, CD22: All positive in 100% of cases, with abnormally bright expression of CD20 and CD22 being particularly characteristic 2, 3
  • HLA-DR: Positive in 100% of cases 4

HCL-Specific Markers (The Diagnostic Quartet)

  • CD11c: Positive in 100% of cases with abnormally bright expression 2, 4, 3
  • CD25: Positive in 80-88% of cases with abnormally bright expression 1, 2, 3
  • CD103: Positive in 89-100% of cases 2, 3
  • CD123: Positive in 100% of cases 2, 3

At least two of these four HCL-restricted markers (CD11c, CD25, CD103, CD123) must be positive to establish the diagnosis 3

Additional Distinguishing Features

  • CD200: Shows strong expression and is particularly useful in difficult cases to differentiate HCL from other B-cell disorders 1
  • Surface immunoglobulin: Positive in 82% of cases with light chain restriction (kappa or lambda) 4

Consistently Negative Markers

  • CD5: Negative 2
  • CD10: Negative (though occasionally positive in 50% per one series) 2, 4
  • CD23: Negative 2

Critical Diagnostic Pitfall

Important caveat: Bone marrow aspiration is often unsuccessful ("dry tap") in classic HCL due to extensive fibrosis, occurring in the majority of cases 1. When this occurs, flow cytometry must be performed on peripheral blood instead, or diagnosis relies on bone marrow trephine biopsy with immunohistochemistry showing the same marker profile 1.

Distinguishing Classic HCL from HCL-Variant

The flow cytometry clearly differentiates these entities:

Classic HCL: CD25+ and CD123+ (both positive) 1

HCL-Variant: CD25− and CD123 variable (usually negative), though CD11c and CD103 may still be positive 1

This distinction is clinically critical as HCL-variant has poor response to purine analogs and requires different treatment approaches 1.

Practical Application

When reviewing flow cytometry results, look for this algorithmic pattern:

  1. Confirm B-cell lineage: CD19+, CD20 (bright)+, CD22 (bright)+
  2. Check the diagnostic quartet: At least 2 of 4 positive (CD11c, CD25, CD103, CD123)
  3. Verify negative markers: CD5−, CD23−
  4. Add CD200 if available: Strong positivity supports HCL 1

The combination of bright CD20/CD22 with bright CD11c plus CD25 positivity is virtually pathognomonic for classic HCL and allows differentiation from splenic marginal zone lymphoma, chronic lymphocytic leukemia, and other villous lymphocyte disorders 1, 2.

References

Related Questions

Do lymphocytes with cytoplasmic projections correlate with hairy cell leukemia?
Are nucleated red blood cells, giant platelets, abnormal lymphocytes, and smudge cells commonly seen in hairy cell leukemia?
How should low hemoglobin and hematocrit be managed in a patient with hairy cell leukemia when transfusions do not raise the levels?
Is bone marrow aspiration required for the diagnosis and staging of hairy cell leukemia (HCL) and chronic lymphocytic leukemia (CLL)?
Do patients with Hairy Cell leukemia have an increased risk of antibiotic‑induced rashes?
What pharmacologic treatments are appropriate for constipation in an adult glioma patient?
What is ejection fraction, what values are considered normal or abnormal, and how should reduced ejection fraction be managed?
When does post‑stroke confusion resolve?
What is the recommended management for abnormal findings on an echocardiogram?
What are the symptoms of neurogenic bladder?
At what blood pressure thresholds does hypertensive encephalopathy develop in pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.